Whether you’re celebrating a funding round, research collaboration, FDA-approval, or commemorating a deal in the biotech space, you’ll find inspiration in the custom designs below.

Gene-Themed Pharmaceutical Deal Tombstone

Lucite deal tombstone commemorating an agreement for global rights to gout treatment drug ARO-XDH. The agreement was reached between Dublin, Ireland-based Horizon Therapeutics and Arrowhead Pharmaceuticals, headquartered in Pasadena, California.

(21ALJ356)
2 Images
Custom Lucite celebrating a deal for global rights to the preclinical "gene-silencing" drug ARO-XDH.

Custom Lucite Embedment with Drug Vial

Lucite embedment with drug vial commemorating a study of a treatment for solid tumor cancer.

(21ADH006)
1 Image

Pill-Themed Bond Offering Tombstone

Financial tombstone marking the successful placement by Siegfried Holding of a senior bond. The Swiss firm provides development and production services to the pharmaceutical and life sciences sectors.

(21LSS233)
2 Images
Back view of crystal tombstone commemorating a senior bond offering by Siegfried Holding. Based in Switzerland, the life sciences company provides both primary and secondary drug manufacturing.

Pill-Themed Private Placement Deal Toy

Crystal deal toy commemorating a private placement by X4 Pharmaceuticals.

(21ALJ247)
2 Images
Financial tombstone marking a private placement by X4 Pharmaceuticals.

Series A Financing Deal Toy

Crystal deal toy commemorating Series A financing for Interius BioTherapeutics,  a preclinical stage gene therapy firm.

(21AKL266)
2 Images
Crystal deal tombstone celebrating Series A financing for Interius BioTherapeutics. The gene therapy developer is based in Philadelphia.

ASX IPO Crystal Commemorative

Crystal commemorative marking the initial public offering of Australian biotech firm Chimeric Therapeutics. The firm is developing a class of cell therapy drugs for the treatment of cancer.

(21ALJ210)
2 Images
Back view of custom crystal celebrating the initial public offering on the Australia Securities Exchange of Chimeric Therapeutics.

Logo-Themed Funding Tombstone

Lucite tombstone commemorating crossover funding for AbSci, a Vancouver, Washington-based biotech firm.

(21ALJ163)
2 Images
Lucite deal toy marking crossover funding provided to biotech firm AbSci.

Biotech IPO Deal Tombstone

Crystal deal tombstone celebrating the initial public offering of Arctic Bioscience. The Norwegian biotech firm makes use of bioactive marine compounds, including herring roe extracts.

(21LJW055)
2 Images
Logo-themed del toy celebrating the listing on the Oslo-based Euronext Growth exchange of Arctic Bioscience. Based in Ørsta, Norway, the biotech firm develops products for pharmaceutical and nutraceutical applications.

Biotech Financial Tombstone

Custom financial tombstone commemorating an offering by Artelo Biosciences, a San Diego-based biopharmaceutical firm.

(20AJH203)
1 Image

Biotech Deal Toys

Beginning on this page, you’ll find galleries with over 90 images of financial tombstones and deal toys from the biotech and life sciences space. You’ll find a number of custom designs playing off visual elements commonly associated with this space, including DNA strands, pills, lab beakers, periodic tables, as well as ones incorporating actual drug vials.

As you might also expect, you’ll see a number of deal toys involving internationally recognized firms and players. These include Takeda Pharmaceutical, Horizon Therapeutics, Gilead Sciences, Roche, Neurocrine, and Bayer. You’ll see as well tombstones commemorating transactions common to this sector involving these and other firms: joint ventures, licensing deals, and development and commercialization agreements.

But you’ll also notice a number of deals commemorated here that may involve far less familiar firms. These include the acquisition of a Dutch company focused on live-cell imaging analytics, and one of an Illinois-based gene therapy firm devoted to the treatment of a rare genetic disorder; the initial public offering of an Australian developer of radiopharmaceutical cancer therapies, and the IPO of a Norwegian biotech making use of marine compounds such as herring roe extract; early-stage funding for a Philadelphia gene engineering startup, and the IPO of an Israeli firm focused on medical applications for lipid-based compounds.

You’ll also notice in these galleries designs not related to any financial transaction. These celebrate a range of awards and employee recognition pieces honoring successful clinical trials, Food and Drug Administration (FDA) and New Drug Application (NDA) submissions, research collaborations and partnerships, and product development milestones.